chrX-67546285-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000044.6(AR):āc.1139C>Gā(p.Pro380Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000342 in 1,203,372 control chromosomes in the GnomAD database, including 2 homozygotes. There are 101 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000044.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AR | NM_000044.6 | c.1139C>G | p.Pro380Arg | missense_variant | 1/8 | ENST00000374690.9 | NP_000035.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AR | ENST00000374690.9 | c.1139C>G | p.Pro380Arg | missense_variant | 1/8 | 1 | NM_000044.6 | ENSP00000363822.3 |
Frequencies
GnomAD3 genomes AF: 0.00182 AC: 205AN: 112339Hom.: 1 Cov.: 24 AF XY: 0.00159 AC XY: 55AN XY: 34513
GnomAD3 exomes AF: 0.000563 AC: 90AN: 159885Hom.: 1 AF XY: 0.000291 AC XY: 15AN XY: 51619
GnomAD4 exome AF: 0.000189 AC: 206AN: 1090981Hom.: 1 Cov.: 55 AF XY: 0.000129 AC XY: 46AN XY: 357719
GnomAD4 genome AF: 0.00182 AC: 205AN: 112391Hom.: 1 Cov.: 24 AF XY: 0.00159 AC XY: 55AN XY: 34575
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 22, 2017 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 27, 2021 | Published functional studies demonstrate reduced DHT-induced transactivation (Tadokoro-Cuccaro et al., 2014); Reported in individuals with partial androgen insensitivity syndrome (Audi et al., 2010; Bermejo-Costa et al., 2015); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25500996, 20150575, 26242926) - |
Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
AR-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 02, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at